ACI "3rd Annual In-House Counsel Forum on Pharmaceutical Antitrust," May 15-16, New York City

American Conference Institute has announced that it will hold the third installment of its “unique antitrust event, designed specifically for the entire pharmaceutical industry…brand names and generics alike," May 15-16, 2007, at the Warwick New York Hotel in New York City.

The conference will feature addresses by FTC Chairman Deborah Platt Majoras, Assistant Attorney General Thomas O. Barnett, and nine other federal and state enforcement officials.  It will also feature faculty from Eli Lilly, Forest Laboratories, Mayne Pharma, Merck, Mylan, Pfizer, Purdue Pharma, Upsher-Smith, and Wyeth.

The following timely topics will be addressed:

• Overcoming the uncertainty that exists with patent settlements and reverse payments
• Examining the role of authorized generics in the market and impact of the FTC study
• Exploring new antitrust concerns with exclusive dealing, tying, and bundling
• Addressing the implications of the FTC Staff Report on the Noerr-Pennington doctrine
• Determining whether product improvements are exclusionary
• Avoiding antitrust dilemmas in mergers and acquisitions
• Drafting and executing licenses that pass antitrust law scrutiny 

The co-chairs for the conference are Thomas Leary of Hogan & Hartson and Seth Silber of Wilson Sonsini Goodrich & Rosati.  Additional details, as well as registration information, are available at the conference website.

ACI is offering Orange Book Blog readers a $200 discount for the conference.  When registering, use discount code 710OBB.

Orange Book Blog is a media partner of this conference.